🇺🇸 FDA
Pipeline program

Benralizumab

ROB0042

Unknown small_molecule active

Quick answer

Benralizumab for Asthma; Eosinophilic is a Unknown program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Asthma; Eosinophilic
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials